To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene MRPL37TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
567 supporting clones for gene MRPL37 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
CR597035 T cells (Jurkat cell line) .a 1 to 1582 1 to 1582 exact tiling clone,   1582/1582
(100 %)
0 diff
(100 %id)
AL557432 T cells (Jurkat cell line), T cells from T cell leukemia .a 1 to 802 1 to 802   fully sequenced,   802/802
(100 %)
0 diff
(100 %id)
BP262150 small intestine .a 1 to 582 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
BP296862   .a 4 to 582 1 to 579       579/579
(100 %)
0 diff
(100 %id)
BU839764 hepatocellular carcinoma, cell line, Liver .a 6 to 940 1 to 937       937/939
(99 %)
16 diff
(98.3 %id)
BX383165   .a 7 to 972 1 to 962       962/962
(100 %)
11 diff
(98.9 %id)
BU849665 ovary, teratocarcinoma, cell line .a 7 to 892 1 to 887       887/888
(99 %)
10 diff
(98.9 %id)
BQ645749 hepatocellular carcinoma, cell line, Liver .a 8 to 932 1 to 928       926/931
(99 %)
8 diff
(99.2 %id)
BQ650451 hepatocellular carcinoma, cell line, Liver .a 8 to 921 1 to 916       916/917
(99 %)
18 diff
(98.1 %id)
TI_57167529   .a 8 to 761 58 to 833       773/837
(92 %)
37 diff
(95.6 %id)
TI_59390612   .a 19 to 773 97 to 867       636/837
(75 %)
27 diff
(96.8 %id)
BI907727 leukocyte .a 20 to 777 1 to 767       744/767
(97 %)
28 diff
(96.4 %id)
BM020886 astrocytoma grade IV, cell line, brain .a 21 to 835 1 to 834       834/835
(99 %)
31 diff
(96.3 %id)
BE386815 melanotic melanoma, skin .a 23 to 679 28 to 682       655/682
(96 %)
6 diff
(99.2 %id)
BM917129 blood, natural killer cells, cell line .a 23 to 985 24 to 991       968/1124
(86 %)
24 diff
(97.9 %id)
BM549385 melanotic melanoma, skin .a 23 to 1047 12 to 1043       1034/1068
(96 %)
31 diff
(97.1 %id)
BQ225467 epithelioid carcinoma, Pancreas .a 23 to 395 1 to 373       373/970
(38 %)
5 diff
(99.5 %id)
BM561876 blood, natural killer cells, cell line .a 24 to 1015 1 to 988       988/988
(100 %)
16 diff
(98.4 %id)
BE899191 adenocarcinoma cell line, ovary .a 25 to 830 1 to 806       804/890
(90 %)
17 diff
(98.1 %id)
BG335823 choriocarcinoma, placenta .a 26 to 694 1 to 668       668/987
(67 %)
4 diff
(99.6 %id)
BG336678 choriocarcinoma, placenta .a 26 to 849 1 to 838       791/854
(92 %)
39 diff
(95.5 %id)
BI257126 cervical carcinoma cell line, cervix .a 26 to 872 28 to 877       850/877
(96 %)
29 diff
(96.7 %id)
BF973157 leiomyosarcoma cell line, uterus .a 27 to 778 1 to 749       749/961
(77 %)
17 diff
(98.3 %id)
BE799434 lung, small cell carcinoma .a 28 to 871 1 to 844       844/963
(87 %)
43 diff
(95.6 %id)
BM469100 embryonal carcinoma, cell line, testis .a 28 to 973 1 to 955       955/955
(100 %)
12 diff
(98.8 %id)
TI_57217627   .a 28 to 878 34 to 886       853/957
(89 %)
13 diff
(98.7 %id)
TI_57197929   .a 28 to 845 32 to 852       821/852
(96 %)
11 diff
(98.8 %id)
CN363419 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 29 to 810 10 to 792       783/792
(98 %)
8 diff
(99.0 %id)
CN363420 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 29 to 415 1 to 387       387/387
(100 %)
0 diff
(100 %id)
BI821252 pooled brain, lung, testis .a 29 to 845 1 to 820       820/820
(100 %)
9 diff
(99.0 %id)
BI754202 brain .a 29 to 878 1 to 852       852/923
(92 %)
8 diff
(99.2 %id)
BM479899 embryonal carcinoma, cell line, testis .a 29 to 981 1 to 964       964/1051
(91 %)
20 diff
(98.1 %id)
CD627969   .a 30 to 694 696 to 33       664/696
(95 %)
10 diff
(98.6 %id)
BE782361 eye, retinoblastoma .a 30 to 681 1 to 651       651/652
(99 %)
2 diff
(99.7 %id)
BE778040 eye, retinoblastoma .a 31 to 796 1 to 766       764/960
(79 %)
30 diff
(96.9 %id)
BQ943417 brain, neuroblastoma, cell line .a 31 to 952 1 to 926       926/927
(99 %)
7 diff
(99.3 %id)
BU553624 ovary, teratocarcinoma, cell line .a 31 to 872 1 to 852       852/952
(89 %)
25 diff
(97.4 %id)
AW249003 lung, small cell carcinoma .a 32 to 576 9 to 553       545/553
(98 %)
0 diff
(100 %id)
BE788864 large cell carcinoma, lung .a 32 to 711 1 to 675       675/937
(72 %)
15 diff
(98.4 %id)
BE897619 melanotic melanoma, skin .a 32 to 694 1 to 663       663/663
(100 %)
2 diff
(99.7 %id)
CX865553 embryonic stem .a 32 to 242 1 to 211       211/211
(100 %)
4 diff
(98.2 %id)
BF796452 lymph, lymphoma, cell line .a 33 to 694 1 to 660       660/792
(83 %)
2 diff
(99.8 %id)
DA135938 alzheimer cortex .a 34 to 578 2 to 545   capped   544/544
(100 %)
0 diff
(100 %id)
BM922816 leukocyte .a 35 to 831 1 to 812       810/1051
(77 %)
18 diff
(98.3 %id)
BQ050006 lymph, lymphoma, cell line .a 36 to 797 1 to 770       770/935
(82 %)
11 diff
(98.9 %id)
CN363431 embryonic stem cells, cell lines H1, H7, andH9 .a 38 to 772 12 to 747       736/747
(98 %)
7 diff
(99.1 %id)
BE891490 melanotic melanoma, skin .a 38 to 560 1 to 523       523/523
(100 %)
0 diff
(100 %id)
BE253425 eye, retinoblastoma .a 39 to 694 1 to 653       653/706
(92 %)
4 diff
(99.5 %id)
BE728090 melanotic melanoma, skin .a 42 to 830 1 to 784       784/785
(99 %)
10 diff
(98.8 %id)
CX752633 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 42 to 791 1 to 748     Submitted on the opposite strand 748/748
(100 %)
3 diff
(99.6 %id)
BE873055 adenocarcinoma, colon .a 44 to 800 1 to 759       733/852
(86 %)
25 diff
(97.1 %id)
BE795871 lung, small cell carcinoma .a 44 to 785 1 to 739       739/751
(98 %)
6 diff
(99.3 %id)
CN363418 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 45 to 570 1 to 526       526/526
(100 %)
4 diff
(99.3 %id)
CN363424 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 45 to 540 1 to 496       496/496
(100 %)
0 diff
(100 %id)
BE386034 melanotic melanoma, skin .a 45 to 694 1 to 649       649/745
(87 %)
6 diff
(99.2 %id)
BE389736 endometrium, adenocarcinoma cell line, uterus .a 46 to 535 1 to 490       490/491
(99 %)
1 diff
(99.8 %id)
BE390160 endometrium, adenocarcinoma cell line, uterus .a 46 to 694 1 to 652       652/690
(94 %)
10 diff
(98.6 %id)
BE386033 melanotic melanoma, skin .a 46 to 694 1 to 645       645/714
(90 %)
4 diff
(99.5 %id)
TI_1948093589   .a 46 to 691 135 to 787       653/1296
(50 %)
32 diff
(97.6 %id)
TI_1948093749   .a 46 to 684 118 to 761       644/1402
(45 %)
27 diff
(98.1 %id)
BE730877 choriocarcinoma, placenta .a 48 to 886 1 to 829       827/941
(87 %)
38 diff
(96.0 %id)
CN274779 embryonic stem cells, DMSO-treated H9 cellline .a 49 to 164 1 to 116       116/116
(100 %)
0 diff
(100 %id)
CV025758 mixed .a 49 to 679 1 to 630       630/630
(100 %)
2 diff
(99.7 %id)
BE796557 lung, small cell carcinoma .a 52 to 871 1 to 812       812/873
(93 %)
17 diff
(98.1 %id)
CD514360 White Matter .a 54 to 929 1 to 882       880/882
(99 %)
6 diff
(99.4 %id)
CB142357 Liver .a 54 to 592 1 to 539       539/539
(100 %)
1 diff
(99.9 %id)
BP347216 brain .a 54 to 635 1 to 583       583/583
(100 %)
3 diff
(99.5 %id)
CN363427 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 56 to 711 1 to 656       656/656
(100 %)
0 diff
(100 %id)
AW402444 lymph .a 57 to 433 8 to 384       377/384
(98 %)
6 diff
(98.5 %id)
TI_154138819   .a 57 to 589 81 to 613       533/533
(100 %)
7 diff
(98.7 %id)
TI_154139283   .a 57 to 694 81 to 725       645/681
(94 %)
27 diff
(96.1 %id)
TI_154186053   .a 57 to 882 121 to 942       822/973
(84 %)
22 diff
(97.8 %id)
TI_154186086   .a 57 to 785 122 to 843       722/926
(77 %)
9 diff
(99.1 %id)
BE540643 cervix .a 64 to 753 1 to 682       684/869
(78 %)
17 diff
(98.1 %id)
BI838930 pooled pancreas and spleen .a 64 to 750 9 to 695       687/695
(98 %)
7 diff
(99.0 %id)
TI_57164547   .a 64 to 750 9 to 695       687/695
(98 %)
7 diff
(99.0 %id)
CV809338 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 66 to 881 1 to 818       818/845
(96 %)
10 diff
(98.9 %id)
BG770738 melanotic melanoma, high MDR (cell line), skin .a 99 to 881 100 to 878       777/921
(84 %)
23 diff
(97.6 %id)
AA355458   .a 110 to 341 1 to 232       232/232
(100 %)
3 diff
(98.8 %id)
BF765296 colon_est .a 118 to 276 3 to 163       161/163
(98 %)
6 diff
(96.4 %id)
BF340029 brain, glioblastoma with EGFR amplification .a 120 to 871 1 to 755       755/944
(79 %)
18 diff
(98.1 %id)
BG821473 adenocarcinoma cell line, colon .a 130 to 832 1 to 702       702/702
(100 %)
2 diff
(99.8 %id)
BE514595 adenocarcinoma cell line, ovary .a 146 to 803 1 to 655       655/656
(99 %)
4 diff
(99.4 %id)
CB123269 Liver .a 152 to 745 1 to 594       594/594
(100 %)
2 diff
(99.7 %id)
BU553890 ovary, teratocarcinoma, cell line .a 165 to 1026 1 to 867       867/870
(99 %)
9 diff
(99.0 %id)
BP224920   .a 167 to 746 1 to 582       582/582
(100 %)
5 diff
(99.2 %id)
BF743357 breast .a 198 to 614 422 to 5     Submitted on the opposite strand 418/436
(95 %)
1 diff
(99.8 %id)
BF746956 breast .a 198 to 614 420 to 3     Submitted on the opposite strand 418/432
(96 %)
0 diff
(100 %id)
CN363428 embryonic stem cells, cell lines H1, H7, andH9 .a 203 to 376 1 to 175       175/175
(100 %)
1 diff
(99.5 %id)
BG676171 skin, squamous cell carcinoma .a 211 to 991 1 to 795       793/795
(99 %)
20 diff
(97.5 %id)
BF954201 nervous_normal .a 225 to 397 21 to 193       173/196
(88 %)
3 diff
(98.5 %id)
BF958706 nervous_normal .a 225 to 397 27 to 198       172/201
(85 %)
2 diff
(99.1 %id)
AW373208 breast .a 234 to 928 1 to 695       695/695
(100 %)
6 diff
(99.2 %id)
BI224230 cervical carcinoma cell line, cervix .a 236 to 1132 1 to 889       889/913
(97 %)
14 diff
(98.5 %id)
BG167087 hypernephroma, cell line, Kidney .a 237 to 1039 1 to 802       802/911
(88 %)
18 diff
(98.1 %id)
BG339354 leiomyosarcoma cell line, uterus .a 239 to 914 1 to 670       670/813
(82 %)
10 diff
(98.8 %id)
BP311258 brain .a 245 to 826 1 to 582       582/582
(100 %)
0 diff
(100 %id)
T31724 colon, embryo .a 251 to 518 1 to 269       269/269
(100 %)
1 diff
(99.7 %id)
BU932668 mixed (pool of 40 RNAs) .a 252 to 1013 1 to 766       766/776
(98 %)
11 diff
(98.6 %id)
BG249980 adenocarcinoma, cell line, Liver .a 256 to 1043 1 to 788       788/1044
(75 %)
16 diff
(98.5 %id)
BP430172   .a 257 to 694 1 to 437       437/437
(100 %)
4 diff
(99.1 %id)
BE811855 amnion_normal .a 266 to 506 259 to 20       240/262
(91 %)
1 diff
(99.7 %id)
AW577203 breast .a 272 to 598 335 to 9       327/359
(91 %)
2 diff
(99.5 %id)
FN147482 breast carcinoma .a 274 to 338 1 to 66       66/66
(100 %)
1 diff
(98.5 %id)
CU445880 epidermis .a 278 to 1001 1 to 725       725/725
(100 %)
6 diff
(99.2 %id)
CU445973 epidermis .a 278 to 915 1 to 639       639/639
(100 %)
6 diff
(99.1 %id)
CU446083 epidermis .a 278 to 932 1 to 656       656/658
(99 %)
7 diff
(99.0 %id)
CU446714 epidermis .a 278 to 929 1 to 655       655/655
(100 %)
8 diff
(98.8 %id)
CU455715 epidermis .a 278 to 966 1 to 690       690/695
(99 %)
5 diff
(99.3 %id)
AA247569   .a 279 to 694 1 to 416       416/416
(100 %)
3 diff
(99.3 %id)
AV653947 corresponding non cancerous liver tissue .a 283 to 661 1 to 379     Submitted on the opposite strand 379/379
(100 %)
3 diff
(99.3 %id)
BI260373 cervical carcinoma cell line, cervix .a 298 to 998 1 to 701       701/701
(100 %)
0 diff
(100 %id)
BG326072 Kidney, renal cell adenocarcinoma .a 301 to 1002 1 to 697       697/702
(99 %)
13 diff
(98.2 %id)
BE547658 cervical carcinoma cell line, cervix .a 304 to 1048 1 to 737       737/809
(91 %)
29 diff
(96.5 %id)
BG826347 muscle, rhabdomyosarcoma .a 310 to 1219 1 to 923       923/928
(99 %)
49 diff
(94.8 %id)
BG826558 muscle, rhabdomyosarcoma .a 310 to 1187 1 to 882       882/882
(100 %)
9 diff
(99.0 %id)
BM791932 Ascites, stomach .a 311 to 940 1 to 630       630/630
(100 %)
3 diff
(99.6 %id)
BF746955 breast .a 319 to 614 313 to 17     Submitted on the opposite strand 297/313
(94 %)
2 diff
(99.4 %id)
AI630498 blood .a 344 to 569 1 to 226       226/226
(100 %)
0 diff
(100 %id)
BI335895 skin .a 344 to 739 1 to 396       396/396
(100 %)
0 diff
(100 %id)
BE811800 amnion_normal .a 352 to 551 200 to 1       200/200
(100 %)
0 diff
(100 %id)
T34420 lung .a 356 to 564 1 to 209       209/209
(100 %)
0 diff
(100 %id)
BI226251 Burkitt lymphoma, lymph .a 366 to 1243 1 to 884       884/951
(92 %)
27 diff
(97.2 %id)
BE906645 epithelioid carcinoma, Pancreas .a 388 to 1138 1 to 748       748/751
(99 %)
11 diff
(98.6 %id)
TI_59392720   .a 388 to 1038 50 to 693       644/677
(95 %)
22 diff
(96.8 %id)
BG714354 brain, hypothalamus .a 394 to 1164 1 to 771       771/772
(99 %)
2 diff
(99.8 %id)
AW960439   .a 398 to 1038 1 to 643       643/661
(97 %)
7 diff
(99.0 %id)
BE792520 lung, small cell carcinoma .a 408 to 1243 1 to 838       838/937
(89 %)
22 diff
(97.7 %id)
BG030394 breast, mammary adenocarcinoma, cell line .a 435 to 1216 1 to 770       770/953
(80 %)
35 diff
(96.4 %id)
CB154995 brain .a 449 to 1045 1 to 597       597/597
(100 %)
0 diff
(100 %id)
BX279846 melanotic melanoma, skin .a 456 to 958 1 to 503       503/503
(100 %)
0 diff
(100 %id)
CN363430 embryonic stem cells, cell lines H1, H7, andH9 .a 456 to 1074 5 to 623       619/623
(99 %)
6 diff
(99.1 %id)
BQ214111 melanotic melanoma, skin .a 458 to 1246 1 to 789       789/883
(89 %)
9 diff
(99.0 %id)
BU957500 adenocarcinoma, cell line, breast .a 462 to 1250 1 to 794       794/973
(81 %)
25 diff
(97.5 %id)
BG179657 adenocarcinoma, cell line, Prostate .a 499 to 1243 1 to 744       744/968
(76 %)
16 diff
(98.4 %id)
AL519148 brain, neuroblastoma, neuroblastoma cells .a 502 to 1242 828 to 85       744/784
(94 %)
7 diff
(99.2 %id)
BE613837 leiomyosarcoma, uterus .a 531 to 1228 1 to 699       699/702
(99 %)
8 diff
(98.9 %id)
BY995807   .a 550 to 1101 1 to 552       552/552
(100 %)
0 diff
(100 %id)
BG163344 hypernephroma, cell line, Kidney .a 572 to 1238 13 to 677       665/951
(69 %)
17 diff
(98.3 %id)
BM852410 Ascites, stomach .a 619 to 1144 1 to 526       526/528
(99 %)
1 diff
(99.9 %id)
CB158935 Liver .a 662 to 1203 1 to 542       542/542
(100 %)
4 diff
(99.3 %id)
BF804297 colon_ins .a 732 to 975 35 to 278       244/278
(87 %)
6 diff
(97.9 %id)
BG951202 colon .a 737 to 1169 1 to 438       438/456
(96 %)
19 diff
(95.9 %id)
AW673445 cervix .a 763 to 1236 1 to 474       474/474
(100 %)
0 diff
(100 %id)
AL579470 T cells (Jurkat cell line), T cells from T cell leukemia .a 772 to 1582 809 to 1   fully sequenced,   809/809
(100 %)
7 diff
(99.2 %id)
BF326737 breast_normal .a 775 to 1217 450 to 1       450/604
(74 %)
17 diff
(97.2 %id)
BF331742 breast .a 775 to 1217 450 to 1       450/604
(74 %)
17 diff
(97.2 %id)
BF349752 head_neck .a 780 to 940 165 to 6       160/165
(96 %)
0 diff
(100 %id)
H42625 breast .a 793 to 1246 1 to 469       469/503
(93 %)
29 diff
(94.3 %id)
BP430597   .a 798 to 1166 1 to 369       369/369
(100 %)
4 diff
(99.0 %id)
H72586 liver and spleen .a 803 to 1250 1 to 460       460/517
(88 %)
11 diff
(97.9 %id)
BF763824 colon_est .a 817 to 1224 1 to 409       409/421
(97 %)
8 diff
(98.1 %id)
AW804748 uterus .a 836 to 1126 296 to 8       289/296
(97 %)
2 diff
(99.4 %id)
AA046512 uterus .a 844 to 1016 1 to 172       172/175
(98 %)
4 diff
(97.8 %id)
BM853671 Ascites, stomach .a 866 to 1243 1 to 380       380/389
(97 %)
10 diff
(97.5 %id)
BE543702 cervical carcinoma cell line, cervix .a 907 to 1243 1 to 346       346/396
(87 %)
18 diff
(95.5 %id)
DW451090 Liver .a 917 to 1099 12 to 194       183/194
(94 %)
6 diff
(97.0 %id)
AW663303 2 pooled high-grade transitional celltumors, genitourinary tract .a 963 to 1255 1 to 297       297/344
(86 %)
16 diff
(95.4 %id)
EC582441 Prostate .a 1049 to 1154 1 to 105       105/105
(100 %)
2 diff
(98.1 %id)
EC583313 Prostate .a 1049 to 1153 1 to 104       104/104
(100 %)
2 diff
(98.1 %id)
AW248563 lung, small cell carcinoma .a 1066 to 1597 542 to 11   AAA   532/532
(100 %)
3 diff
(99.5 %id)
FN113192 breast carcinoma .a 1083 to 1156 74 to 1     Submitted on the opposite strand 74/74
(100 %)
1 diff
(98.7 %id)
EC580695 Prostate .a 1084 to 1192 1 to 105       105/105
(100 %)
5 diff
(95.3 %id)
EC550717 Prostate .a 1087 to 1192 8 to 115       108/115
(93 %)
9 diff
(92.2 %id)
EC522950 Prostate .a 1093 to 1192 13 to 112       100/112
(89 %)
6 diff
(94.7 %id)
AA933709 pooled germ cell tumors .a 1179 to 1601 422 to 1       422/422
(100 %)
1 diff
(99.8 %id)
BQ185908 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 1181 to 1597 1 to 417   AAA   417/417
(100 %)
0 diff
(100 %id)
AA835828 germinal center B cell .a 1550 to 1902 18 to 370       353/370
(95 %)
6 diff
(98.4 %id)
DB548548.
matches multiple genes
hippocampus .a 1551 to 2006 456 to 1   tiling clone, also hits gene SSBP3 456/456
(100 %)
0 diff
(100 %id)
DB554138 hypothalamus .a 1551 to 1973 424 to 1       424/424
(100 %)
4 diff
(99.1 %id)
DB567670.
matches multiple genes
hypothalamus .a 1551 to 1956 406 to 1     also hits gene SSBP3 406/406
(100 %)
1 diff
(99.8 %id)
AW373594 breast .a 1577 to 2221 10 to 653       644/653
(98 %)
6 diff
(99.1 %id)
BE218566 carcinoid, lung .a 1579 to 2093 515 to 1       515/515
(100 %)
1 diff
(99.9 %id)
AW937627 denis_drash .a 1590 to 2141 1 to 553       553/553
(100 %)
4 diff
(99.3 %id)
BF448230 carcinoid, lung .a 1603 to 2117 517 to 2       516/517
(99 %)
0 diff
(100 %id)
BF002067 colon, colon tumor, RER+ .a 1630 to 2093 465 to 1       465/465
(100 %)
4 diff
(99.2 %id)
AA515310 colon .a 1667 to 2093 426 to 1       426/426
(100 %)
1 diff
(99.8 %id)
DR759680 embryonic stem .a 1692 to 2422 21 to 751   tiling clone,   731/751
(97 %)
6 diff
(99.3 %id)
CB160683 Liver .a 1783 to 2293 1 to 511       511/511
(100 %)
0 diff
(100 %id)
BP420405 small intestine .a 1865 to 2313 450 to 1       450/450
(100 %)
1 diff
(99.8 %id)
AW937594 denis_drash .a 1953 to 2455 1 to 504       504/504
(100 %)
5 diff
(99.1 %id)
FN052544 breast carcinoma .a 2141 to 2195 1 to 54       54/55
(98 %)
2 diff
(96.4 %id)
CD637332   .a 2147 to 2749 1 to 602       602/602
(100 %)
2 diff
(99.7 %id)
BM311722 Pancreas, Purified pancreatic islet .a 2280 to 2845 569 to 1   tiling clone,   569/569
(100 %)
1 diff
(99.9 %id)
AI380164 brain, glioblastoma (pooled) .a 2466 to 2885 420 to 1       420/420
(100 %)
4 diff
(99.1 %id)
GD160811   .a 2509 to 2635 1 to 127       127/147
(86 %)
6 diff
(96.0 %id)
TI_149278732   .a 2549 to 2871 404 to 82   AAA   323/687
(47 %)
1 diff
(99.9 %id)
DB576011.
matches multiple genes
hypothalamus .a 2641 to 3126 487 to 1     also hits gene SSBP3 487/487
(100 %)
1 diff
(99.8 %id)
AA568413   .a 2772 to 3174 1 to 402   tiling clone,   402/402
(100 %)
3 diff
(99.3 %id)
CK822388 Pancreas, Purified pancreatic islet .a 2792 to 3081 1 to 290       290/290
(100 %)
0 diff
(100 %id)
CK824806 Pancreas, Purified pancreatic islet .a 2797 to 3064 1 to 267   fully sequenced,   267/267
(100 %)
2 diff
(99.3 %id)
BP397396 pancreatic islet .a 2798 to 3117 320 to 1       320/320
(100 %)
0 diff
(100 %id)
BG656522 Pancreas, Purified pancreatic islet .a 2801 to 3002 1 to 202       202/202
(100 %)
0 diff
(100 %id)
BP395195 pancreatic islet .a 2802 to 3090 289 to 1       289/289
(100 %)
0 diff
(100 %id)
CK824805 Pancreas, Purified pancreatic islet .a 2842 to 3036 195 to 1   fully sequenced,   195/195
(100 %)
0 diff
(100 %id)
BG327848 Kidney, renal cell adenocarcinoma .b 1 to 834 1 to 826   tiling clone,   826/890
(92 %)
28 diff
(96.9 %id)
BI670000 brain, hypothalamus .b 16 to 545 1 to 530       530/530
(100 %)
4 diff
(99.3 %id)
BG702686 brain, hippocampus .b 19 to 699 1 to 681       681/681
(100 %)
5 diff
(99.3 %id)
BM796296 stomach .b 20 to 599 1 to 580       580/580
(100 %)
0 diff
(100 %id)
BP381937 adipose tissue .b 21 to 646 1 to 626       626/626
(100 %)
0 diff
(100 %id)
AK024572 adipose tissue .b 21 to 1497 1 to 1477 exact tiling clone, available from FLJ, AAA   1477/1477
(100 %)
2 diff
(99.9 %id)
TI_44343214   .b 21 to 774 134 to 902       769/1010
(76 %)
19 diff
(98.2 %id)
TI_44345305   .b 21 to 545 92 to 616       525/616
(85 %)
8 diff
(98.8 %id)
BP269904 thyroid .b 21 to 604 1 to 583       583/583
(100 %)
3 diff
(99.5 %id)
CB157255 Liver .b 21 to 576 1 to 556       556/556
(100 %)
0 diff
(100 %id)
BP303260   .b 21 to 597 1 to 581       581/581
(100 %)
4 diff
(99.4 %id)
NM_016491.3   .b 21 to 1507 1 to 1487 exact RefSeq,   1487/1487
(100 %)
4 diff
(99.8 %id)
DA568111 whole embryo, mainly head .b 22 to 736 2 to 720   capped   719/753
(95 %)
7 diff
(99.1 %id)
DA609150   .b 22 to 515 2 to 495   capped   494/494
(100 %)
0 diff
(100 %id)
DA612761   .b 22 to 608 2 to 588   capped   587/587
(100 %)
0 diff
(100 %id)
DA695887   .b 22 to 499 2 to 479   capped   478/478
(100 %)
1 diff
(99.8 %id)
DA731587   .b 22 to 740 2 to 723   capped   722/743
(97 %)
9 diff
(98.8 %id)
DB120729 thymus .b 22 to 589 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
DA687753   .b 23 to 568 2 to 547   capped   546/546
(100 %)
1 diff
(99.9 %id)
BP871047 embryonal kidney .b 24 to 355 1 to 332       332/332
(100 %)
0 diff
(100 %id)
BP871104 embryonal kidney .b 24 to 355 1 to 332       332/332
(100 %)
0 diff
(100 %id)
DT220036 brain .b 24 to 582 1 to 557       557/557
(100 %)
2 diff
(99.7 %id)
DT220629 brain .b 24 to 611 1 to 588       588/588
(100 %)
1 diff
(99.9 %id)
DB485360 hypothalamus .b 24 to 482 1 to 459       459/459
(100 %)
7 diff
(98.5 %id)
CB113571 Liver .b 24 to 214 1 to 191       191/191
(100 %)
0 diff
(100 %id)
BP307441 brain .b 24 to 615 1 to 592       592/592
(100 %)
4 diff
(99.4 %id)
BM739368 Ascites, stomach .b 24 to 622 1 to 599       599/599
(100 %)
0 diff
(100 %id)
BM770985 Ascites, stomach .b 24 to 425 1 to 402       402/402
(100 %)
0 diff
(100 %id)
DA068164 cerebellum .b 25 to 596 2 to 574   capped   573/573
(100 %)
1 diff
(99.9 %id)
CR599560 HeLa cells Cot 25-normalized .b 25 to 1464 1 to 1440 exact     1440/1440
(100 %)
0 diff
(100 %id)
BX401225   .b 25 to 774 1 to 749   fully sequenced,   749/749
(100 %)
0 diff
(100 %id)
DA618296   .b 25 to 509 2 to 489   capped   488/488
(100 %)
3 diff
(99.4 %id)
TI_57220696   .b 25 to 827 26 to 831       804/1041
(77 %)
19 diff
(98.2 %id)
DA734517   .b 25 to 589 2 to 567   capped   566/575
(98 %)
3 diff
(99.5 %id)
DB294665   .b 25 to 708 2 to 686   capped   685/685
(100 %)
3 diff
(99.6 %id)
CA405428 adipose .b 27 to 294 1 to 268       268/268
(100 %)
0 diff
(100 %id)
BM459325 lymph, lymphoma, cell line .b 27 to 700 5 to 681       677/967
(70 %)
14 diff
(98.6 %id)
BP300188   .b 28 to 609 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
BP300344   .b 28 to 586 1 to 559       559/559
(100 %)
0 diff
(100 %id)
BP368826 testis .b 28 to 607 1 to 580       580/580
(100 %)
0 diff
(100 %id)
BI550797 brain, hippocampus .b 29 to 772 1 to 744       744/756
(98 %)
5 diff
(99.4 %id)
DB154347 thymus .b 29 to 596 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
CN363423 embryonic stem cells, DMSO-treated H9 cellline .b 32 to 807 1 to 779       779/779
(100 %)
7 diff
(99.2 %id)
CN363425 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 32 to 606 1 to 575       575/575
(100 %)
2 diff
(99.7 %id)
BP271882   .b 32 to 630 9 to 607       599/607
(98 %)
6 diff
(99.1 %id)
BG686809 B-cells, primary B-cells from tonsils (cell line) .b 34 to 803 1 to 770       770/771
(99 %)
2 diff
(99.8 %id)
BG759018 B-cells, primary B-cells from tonsils (cell line) .b 34 to 852 1 to 820       820/824
(99 %)
3 diff
(99.7 %id)
BG757549 B-cells, primary B-cells from tonsils (cell line) .b 34 to 707 1 to 674       674/674
(100 %)
2 diff
(99.8 %id)
BI757764 brain .b 34 to 827 1 to 798       796/1008
(78 %)
14 diff
(98.7 %id)
TI_59389363   .b 34 to 834 103 to 953       702/852
(82 %)
35 diff
(95.9 %id)
BI195908 brain, neuroblastoma .b 35 to 875 1 to 839       839/880
(95 %)
22 diff
(97.5 %id)
BM560716 astrocytoma grade IV, cell line, brain .b 35 to 930 1 to 908       908/1094
(82 %)
27 diff
(97.6 %id)
BM924817 pooled colon, kidney, stomach .b 35 to 1034 18 to 1023       1006/1107
(90 %)
23 diff
(98.0 %id)
BQ069608 brain, neuroblastoma, cell line .b 35 to 930 1 to 901       899/1047
(85 %)
22 diff
(97.9 %id)
BU180646 eye, retinoblastoma .b 35 to 889 1 to 862       862/867
(99 %)
18 diff
(98.0 %id)
TI_59392847   .b 35 to 881 47 to 895       849/849
(100 %)
15 diff
(98.3 %id)
BM014788 breast, mammary adenocarcinoma, cell line .b 36 to 881 1 to 848       848/848
(100 %)
15 diff
(98.3 %id)
CA488252   .b 36 to 892 1 to 866       866/880
(98 %)
11 diff
(98.8 %id)
BP331804 renal proximal tubule .b 36 to 607 1 to 572       572/572
(100 %)
4 diff
(99.4 %id)
BP382090 adipose tissue .b 37 to 662 1 to 626       626/626
(100 %)
2 diff
(99.7 %id)
AK026171   .b 37 to 1501 1 to 1465 C366S available from FLJ, AAA   1465/1465
(100 %)
4 diff
(99.8 %id)
DB456468 testis .b 37 to 546 1 to 509       509/509
(100 %)
2 diff
(99.7 %id)
BP326208 prostata .b 37 to 620 1 to 584       584/584
(100 %)
0 diff
(100 %id)
BP327513 prostata .b 37 to 617 1 to 581       581/581
(100 %)
0 diff
(100 %id)
DA160557 amygdala .b 38 to 608 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
BG335000 choriocarcinoma, placenta .b 38 to 743 1 to 707       707/858
(82 %)
12 diff
(98.7 %id)
DA613883   .b 38 to 600 2 to 569   capped   568/568
(100 %)
5 diff
(99.2 %id)
DA912856   .b 38 to 603 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
DB190732 lung, tumor tissue .b 38 to 609 2 to 574   capped   573/573
(100 %)
1 diff
(99.9 %id)
CX759845 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .b 39 to 750 1 to 705     Submitted on the opposite strand 705/833
(84 %)
11 diff
(98.7 %id)
CD244466 testis .b 39 to 858 1 to 825       825/825
(100 %)
6 diff
(99.3 %id)
CD050390 embryonic trophoblasts, made from WA01 stemcells .b 40 to 892 17 to 872       856/872
(98 %)
10 diff
(98.9 %id)
TI_45379083   .b 40 to 875 28 to 862       835/867
(96 %)
12 diff
(98.7 %id)
TI_57149633   .b 40 to 823 55 to 835       781/835
(93 %)
9 diff
(99.0 %id)
TI_57164474   .b 40 to 823 58 to 844       787/844
(93 %)
16 diff
(98.2 %id)
CN363426 embryonic stem cells, cell lines H1, H7, andH9 .b 41 to 611 1 to 570       570/570
(100 %)
1 diff
(99.9 %id)
BP303564   .b 41 to 621 1 to 581       581/581
(100 %)
0 diff
(100 %id)
BP329251 rectum .b 41 to 621 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
CB150649 cervix, Uterine .b 42 to 694 1 to 653       653/653
(100 %)
1 diff
(99.9 %id)
DA542057 lung .b 42 to 627 2 to 587   capped   586/586
(100 %)
1 diff
(99.9 %id)
BM761172 lymph node, stomach .b 42 to 592 8 to 558       551/558
(98 %)
6 diff
(99.0 %id)
BM842658 lymph node, stomach .b 42 to 668 8 to 634       627/634
(98 %)
6 diff
(99.1 %id)
DA427658 colon .b 43 to 538 2 to 497   capped   496/496
(100 %)
3 diff
(99.4 %id)
CR598610 B cells (Ramos cell line) .b 43 to 1478 1 to 1436 exact     1436/1436
(100 %)
0 diff
(100 %id)
AL559825 B cells (Ramos cell line), B cells from Burkitt lymphoma .b 43 to 774 1 to 731   fully sequenced,   731/731
(100 %)
1 diff
(99.9 %id)
BG420475 Kidney, renal cell adenocarcinoma .b 43 to 743 1 to 696       696/711
(97 %)
9 diff
(98.8 %id)
BG769259 melanotic melanoma, high MDR (cell line), skin .b 44 to 879 1 to 840       840/844
(99 %)
19 diff
(97.8 %id)
BP300836   .b 44 to 625 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
TI_154139795   .b 44 to 662 78 to 693       616/616
(100 %)
10 diff
(98.4 %id)
DA000234   .b 45 to 555 2 to 512   capped   511/511
(100 %)
0 diff
(100 %id)
DA242256 brain .b 45 to 648 2 to 606   capped   605/605
(100 %)
1 diff
(99.9 %id)
BG616296 embryonal carcinoma, testis .b 45 to 763 1 to 726       726/768
(94 %)
23 diff
(97.1 %id)
BG700845 brain, hippocampus .b 45 to 916 1 to 868       868/873
(99 %)
17 diff
(98.1 %id)
BM542768 leiomyosarcoma, uterus .b 45 to 740 1 to 699       699/1051
(66 %)
10 diff
(99.1 %id)
CX785166 human embryonic stem cells .b 45 to 302 1 to 258       258/258
(100 %)
0 diff
(100 %id)
TI_57180910   .b 45 to 900 63 to 916       854/916
(93 %)
9 diff
(99.1 %id)
DA912008   .b 45 to 605 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
TI_154137730   .b 46 to 446 78 to 478       401/597
(67 %)
8 diff
(98.7 %id)
CR618152 Neuroblastoma Cot 25-normalized .b 47 to 1489 1 to 1443 exact     1443/1443
(100 %)
0 diff
(100 %id)
BX375319 Neuroblastoma Cot 25-normalized .b 47 to 914 1 to 867   fully sequenced,   867/867
(100 %)
4 diff
(99.6 %id)
DA495074 brain .b 47 to 596 2 to 551   capped   550/551
(99 %)
2 diff
(99.7 %id)
BG337292 leiomyosarcoma cell line, uterus .b 47 to 871 1 to 822       822/823
(99 %)
7 diff
(99.2 %id)
BI759612 pooled colon, kidney, stomach .b 47 to 823 1 to 774       774/774
(100 %)
3 diff
(99.7 %id)
BI488562 brain .b 47 to 875 1 to 828       828/833
(99 %)
6 diff
(99.3 %id)
BI834144 pooled pancreas and spleen .b 47 to 823 1 to 780       780/780
(100 %)
12 diff
(98.5 %id)
BM043797 carcinoma, cell line, Prostate .b 47 to 776 1 to 730       730/730
(100 %)
1 diff
(99.9 %id)
BM047343 carcinoma, cell line, Prostate .b 47 to 827 1 to 783       783/967
(80 %)
14 diff
(98.6 %id)
CX785532 human embryonic stem cells .b 47 to 822 1 to 776       776/776
(100 %)
0 diff
(100 %id)
CD693146 normal nasopharynx .b 48 to 690 23 to 665       643/665
(96 %)
6 diff
(99.1 %id)
DA341974 substantia nigra .b 49 to 532 2 to 485   capped   484/484
(100 %)
0 diff
(100 %id)
TI_45235513   .b 49 to 822 59 to 838   fully sequenced,   780/838
(93 %)
10 diff
(98.9 %id)
DB024592 testis .b 49 to 598 2 to 552   capped   551/551
(100 %)
1 diff
(99.9 %id)
CR604411 Placenta Cot 25-normalized .b 51 to 1471 1 to 1421 exact     1421/1421
(100 %)
0 diff
(100 %id)
BX397130 Placenta Cot 25-normalized .b 51 to 774 1 to 724   fully sequenced,   724/724
(100 %)
0 diff
(100 %id)
BI768642 pooled lung and spleen .b 51 to 900 1 to 848       848/848
(100 %)
3 diff
(99.7 %id)
BQ951610 epidermoid carcinoma, cell line, lung .b 51 to 843 1 to 802       802/895
(89 %)
11 diff
(98.8 %id)
DR763420 embryonic stem .b 52 to 732 1 to 681       681/681
(100 %)
0 diff
(100 %id)
BM846840 myeloma .b 52 to 593 1 to 542       542/542
(100 %)
0 diff
(100 %id)
BE255713 eye, retinoblastoma .b 53 to 742 1 to 688       688/707
(97 %)
15 diff
(97.9 %id)
BF203197 muscle, rhabdomyosarcoma .b 53 to 810 1 to 755       755/953
(79 %)
15 diff
(98.5 %id)
BG766982 melanotic melanoma, high MDR (cell line), skin .b 53 to 816 1 to 762       759/931
(81 %)
27 diff
(97.1 %id)
BQ686265 ductal carcinoma, cell line, Pancreas .b 53 to 930 1 to 883       883/885
(99 %)
14 diff
(98.5 %id)
BQ877415 ductal carcinoma, cell line, Pancreas .b 53 to 743 1 to 695       695/792
(87 %)
7 diff
(99.2 %id)
BM751140 Ascites, stomach .b 53 to 506 1 to 454       454/454
(100 %)
3 diff
(99.4 %id)
AF151069 umbilical cord blood .b 54 to 1497 1 to 1437 R9S R10A A11K L12H A13G ... AAA   1437/1437
(100 %)
8 diff
(99.5 %id)
DA059338 cerebellum .b 54 to 608 2 to 557   capped   556/556
(100 %)
1 diff
(99.9 %id)
DA431870 colon .b 54 to 596 2 to 544   capped   543/543
(100 %)
0 diff
(100 %id)
BE259053 eye, retinoblastoma .b 54 to 739 16 to 703       688/704
(97 %)
12 diff
(98.3 %id)
BG828878 muscle, rhabdomyosarcoma .b 54 to 701 1 to 648       648/648
(100 %)
1 diff
(99.9 %id)
DA897383 skeletal muscle .b 54 to 582 2 to 530   capped   529/529
(100 %)
0 diff
(100 %id)
DA898983 skeletal muscle .b 54 to 509 2 to 458   capped   457/457
(100 %)
1 diff
(99.8 %id)
DB057526 testis .b 54 to 538 2 to 486   capped   485/485
(100 %)
0 diff
(100 %id)
AW246377 lung, small cell carcinoma .b 55 to 685 10 to 640       631/640
(98 %)
8 diff
(98.8 %id)
BE383127 brain, neuroblastoma .b 55 to 808 1 to 765       765/790
(96 %)
29 diff
(96.4 %id)
BE784458 large cell carcinoma, lung .b 55 to 286 1 to 232       232/232
(100 %)
0 diff
(100 %id)
BI113908 muscle, rhabdomyosarcoma .b 55 to 919 1 to 867       867/870
(99 %)
25 diff
(97.2 %id)
BU193117 epithelioid carcinoma, Pancreas .b 55 to 742 7 to 698       692/925
(74 %)
13 diff
(98.6 %id)
AI910258 breast .b 56 to 361 11 to 316       306/316
(96 %)
6 diff
(98.2 %id)
CR594129 HeLa cells Cot 25-normalized .b 56 to 1465 1 to 1410 exact     1410/1410
(100 %)
0 diff
(100 %id)
BX384641   .b 56 to 774 1 to 718   fully sequenced,   718/718
(100 %)
1 diff
(99.9 %id)
BE904169 epithelioid carcinoma, Pancreas .b 56 to 805 1 to 750       750/1102
(68 %)
22 diff
(98.1 %id)
BM477533 lymph, lymphoma, cell line .b 56 to 930 1 to 875       875/1058
(82 %)
5 diff
(99.6 %id)
BE889743 leiomyosarcoma, uterus .b 57 to 336 1 to 287       287/287
(100 %)
4 diff
(98.7 %id)
BG341572 B-cells, primary B-cells from tonsils (cell line) .b 57 to 700 1 to 644       644/644
(100 %)
1 diff
(99.9 %id)
BG421293 Kidney, renal cell adenocarcinoma .b 57 to 777 1 to 731       729/875
(83 %)
21 diff
(97.6 %id)
BI334796 cervical carcinoma cell line, cervix .b 58 to 830 1 to 783       783/933
(83 %)
19 diff
(98.0 %id)
BI333810 cervical carcinoma cell line, cervix .b 58 to 645 1 to 588       588/591
(99 %)
2 diff
(99.7 %id)
BE868094 adenocarcinoma, colon .b 59 to 763 1 to 705       705/707
(99 %)
3 diff
(99.6 %id)
CR610782 HeLa cells Cot 25-normalized .b 60 to 1444 1 to 1385 exact     1385/1385
(100 %)
0 diff
(100 %id)
AL555381 placenta .b 60 to 774 1 to 714   fully sequenced,   714/714
(100 %)
2 diff
(99.8 %id)
BP424560 small intestine .b 60 to 564 1 to 505     Submitted on the opposite strand 505/505
(100 %)
0 diff
(100 %id)
AW408262 lymph .b 60 to 496 1 to 437       437/437
(100 %)
5 diff
(98.9 %id)
BI093734 cervix .b 60 to 879 1 to 817       817/817
(100 %)
15 diff
(98.2 %id)
BQ052929 blood, natural killer cells, cell line .b 60 to 743 1 to 685       685/1096
(62 %)
5 diff
(99.6 %id)
BQ230728 epithelioid carcinoma, Pancreas .b 60 to 908 1 to 859       859/891
(96 %)
17 diff
(98.1 %id)
BU520931 leiomyosarcoma, uterus .b 60 to 914 1 to 872       872/875
(99 %)
24 diff
(97.3 %id)
CX752427 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .b 60 to 834 31 to 796     Submitted on the opposite strand 766/801
(95 %)
21 diff
(97.4 %id)
TI_57181716   .b 60 to 870 33 to 844       812/844
(96 %)
16 diff
(98.2 %id)
CR615286 Neuroblastoma Cot 25-normalized .b 61 to 1472 1 to 1412 exact     1412/1412
(100 %)
0 diff
(100 %id)
BX354854 Neuroblastoma Cot 25-normalized .b 61 to 774 1 to 713   fully sequenced,   713/713
(100 %)
0 diff
(100 %id)
BG393592 embryonal carcinoma, cell line, testis .b 61 to 740 1 to 678       678/815
(83 %)
7 diff
(99.2 %id)
BQ424308 eye, retinoblastoma .b 61 to 830 1 to 781       781/944
(82 %)
21 diff
(97.8 %id)
CN363429 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 62 to 760 1 to 699       699/699
(100 %)
0 diff
(100 %id)
CR611248 T cells (Jurkat cell line) .b 63 to 1500 1 to 1438 exact tiling clone,   1438/1438
(100 %)
0 diff
(100 %id)
BM471016 leiomyosarcoma, uterus .b 63 to 743 29 to 710       682/1207
(56 %)
16 diff
(98.7 %id)
TI_57234760   .b 63 to 826 26 to 798       771/798
(96 %)
33 diff
(95.9 %id)
CD107521 brain, Pituitary .b 64 to 858 27 to 833       807/931
(86 %)
27 diff
(97.1 %id)
TI_57149024   .b 64 to 930 27 to 895       869/932
(93 %)
20 diff
(97.9 %id)
CF134964 CNCAP(3)T-225 cell line, Prostate .b 65 to 482 1 to 418       418/418
(100 %)
5 diff
(98.9 %id)
CN480992 eye .b 66 to 663 1 to 598       598/598
(100 %)
0 diff
(100 %id)
BI768898 pooled lung and spleen .b 66 to 870 1 to 806       806/806
(100 %)
10 diff
(98.8 %id)
BG106946 lymph, lymphoma, cell line .b 67 to 712 1 to 643       643/906
(70 %)
4 diff
(99.6 %id)
BI255963 cervical carcinoma cell line, cervix .b 67 to 827 1 to 761       761/761
(100 %)
0 diff
(100 %id)
BQ421653 melanotic melanoma, skin .b 67 to 921 1 to 859       859/901
(95 %)
12 diff
(98.7 %id)
TI_154147717   .b 67 to 738 79 to 751       673/690
(97 %)
14 diff
(98.0 %id)
TI_59389102   .b 68 to 812 112 to 856       745/745
(100 %)
1 diff
(99.9 %id)
TI_59391161   .b 68 to 740 101 to 781       679/1047
(64 %)
28 diff
(97.4 %id)
TI_57230920   .b 69 to 809 49 to 789       741/744
(99 %)
2 diff
(99.8 %id)
BE392389 endometrium, adenocarcinoma cell line, uterus .b 70 to 576 1 to 507       507/507
(100 %)
0 diff
(100 %id)
BE886505 leiomyosarcoma, uterus .b 70 to 831 1 to 762       762/775
(98 %)
19 diff
(97.6 %id)
BG339880 leiomyosarcoma cell line, uterus .b 70 to 879 1 to 805       805/807
(99 %)
23 diff
(97.2 %id)
BG438048 large cell carcinoma, lung .b 70 to 907 1 to 846       846/849
(99 %)
30 diff
(96.5 %id)
BI870442 adenocarcinoma, cell line, Liver .b 70 to 809 1 to 740       740/743
(99 %)
2 diff
(99.8 %id)
BM020985 astrocytoma grade IV, cell line, brain .b 70 to 812 1 to 743       743/743
(100 %)
1 diff
(99.9 %id)
CN363422 embryonic stem cells, cell lines H1, H7, andH9 .b 71 to 759 1 to 689       689/689
(100 %)
1 diff
(99.9 %id)
BE378621 endometrium, adenocarcinoma cell line, uterus .b 71 to 877 1 to 805       805/953
(84 %)
15 diff
(98.5 %id)
BG282393 melanotic melanoma, skin .b 71 to 900 1 to 831       831/950
(87 %)
25 diff
(97.4 %id)
BM552228 astrocytoma grade IV, cell line, brain .b 71 to 927 1 to 862       862/1034
(83 %)
26 diff
(97.5 %id)
CV802837 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .b 71 to 739 1 to 665       665/835
(79 %)
10 diff
(98.9 %id)
BE741986 adenocarcinoma cell line, ovary .b 72 to 920 10 to 852       843/980
(86 %)
20 diff
(98.0 %id)
BI761611 pooled colon, kidney, stomach .b 72 to 930 1 to 861       861/898
(95 %)
14 diff
(98.5 %id)
TI_154163134   .b 72 to 743 80 to 754       675/722
(93 %)
12 diff
(98.4 %id)
AF325707 skeletal muscle .b 73 to 1496 1 to 1423 C366S     1423/1430
(99 %)
5 diff
(99.7 %id)
CB594767 Blood, promyelocytic leukemia .b 73 to 933 1 to 865       865/892
(96 %)
11 diff
(98.8 %id)
BE264044 lung, small cell carcinoma .b 74 to 781 1 to 709       709/726
(97 %)
12 diff
(98.4 %id)
BG334934 melanotic melanoma, skin .b 75 to 883 1 to 813       813/819
(99 %)
27 diff
(96.8 %id)
BU186702 large cell carcinoma, lung .b 75 to 927 1 to 859       859/902
(95 %)
22 diff
(97.6 %id)
BC000041 Placenta, choriocarcinoma .b 76 to 1497 1 to 1422 exact available from MGC, AAA   1422/1422
(100 %)
2 diff
(99.9 %id)
BQ954601 large cell carcinoma, lung .b 76 to 927 1 to 853       853/853
(100 %)
1 diff
(99.9 %id)
BM466359 embryonal carcinoma, cell line, testis .b 77 to 740 1 to 667       667/1167
(57 %)
11 diff
(99.1 %id)
BM722684 eye, fetal eye .b 83 to 690 1 to 608       608/608
(100 %)
0 diff
(100 %id)
TI_1948093917   .b 95 to 791 132 to 828   fully sequenced,   697/828
(84 %)
6 diff
(99.3 %id)
TI_1948094085   .b 95 to 774 125 to 803   fully sequenced,   679/803
(84 %)
7 diff
(99.2 %id)
BX444309 adult brain, brain .b 449 to 1452 1010 to 10       1001/1010
(99 %)
4 diff
(99.7 %id)
CR625978 Placenta Cot 25-normalized .b 451 to 1498 1 to 1048       1048/1048
(100 %)
0 diff
(100 %id)
AA100137 Pancreas .b 453 to 838 1 to 389       389/389
(100 %)
3 diff
(99.3 %id)
BX361649   .b 455 to 1464 1006 to 1       1004/1006
(99 %)
24 diff
(97.7 %id)
BX394439 Neuroblastoma Cot 25-normalized .b 464 to 1461 993 to 1       993/993
(100 %)
7 diff
(99.3 %id)
AW674799 cervix .b 471 to 794 1 to 324       324/324
(100 %)
0 diff
(100 %id)
AA486034   .b 489 to 1029 1 to 541   fully sequenced,   541/541
(100 %)
0 diff
(100 %id)
BQ670198 epidermoid carcinoma, cell line, salivary gland .b 504 to 1365 1 to 870       870/884
(98 %)
14 diff
(98.5 %id)
BM700438 eye, lens .b 507 to 960 1 to 454   fully sequenced,   454/454
(100 %)
0 diff
(100 %id)
BU956278 adenocarcinoma, cell line, breast .b 511 to 1347 1 to 844       844/889
(94 %)
15 diff
(98.4 %id)
BX464477 neuroblastoma .b 523 to 1463 952 to 16       937/952
(98 %)
30 diff
(96.9 %id)
TI_159723863   .b 525 to 1497 1011 to 59   AAA   953/1007
(94 %)
31 diff
(97.0 %id)
BE614444 leiomyosarcoma, uterus .b 588 to 1481 901 to 7       895/909
(98 %)
24 diff
(97.4 %id)
TI_149286808   .b 621 to 1497 949 to 73   AAA   877/1150
(76 %)
32 diff
(97.3 %id)
BG282800 adenocarcinoma, cell line, Prostate .b 622 to 1380 1 to 754       754/962
(78 %)
20 diff
(98.0 %id)
TI_149275911   .b 627 to 1497 960 to 101   AAA   860/992
(86 %)
22 diff
(97.8 %id)
TI_149315531   .b 627 to 1495 942 to 87   AAA   858/984
(87 %)
21 diff
(97.9 %id)
CD627967   .b 634 to 1381 750 to 4       747/750
(99 %)
6 diff
(99.2 %id)
TI_154125208   .b 663 to 1501 902 to 69   AAA   836/959
(87 %)
26 diff
(97.3 %id)
TI_154111637   .b 684 to 1501 884 to 77   AAA   810/916
(88 %)
18 diff
(98.1 %id)
AW674062 cervix .b 685 to 1005 1 to 322       322/322
(100 %)
1 diff
(99.7 %id)
BE869229 adenocarcinoma, colon .b 696 to 1333 1 to 638       638/638
(100 %)
3 diff
(99.6 %id)
BQ278114 ovary, teratocarcinoma, cell line .b 697 to 1497 1 to 801   AAA   801/801
(100 %)
8 diff
(99.1 %id)
BG420796 Kidney, renal cell adenocarcinoma .b 699 to 1433 1 to 731       731/864
(84 %)
9 diff
(99.0 %id)
BG742270 skin .b 711 to 1398 1 to 688       688/688
(100 %)
4 diff
(99.5 %id)
BX354853 Neuroblastoma Cot 25-normalized .b 713 to 1472 759 to 1   fully sequenced,   759/759
(100 %)
4 diff
(99.5 %id)
AL581366 B cells (Ramos cell line), B cells from Burkitt lymphoma .b 713 to 1478 766 to 1   fully sequenced,   766/766
(100 %)
16 diff
(98.0 %id)
BX397129 Placenta Cot 25-normalized .b 713 to 1449 759 to 22   fully sequenced,   738/759
(97 %)
2 diff
(99.8 %id)
AL555380 placenta .b 713 to 1444 732 to 1   fully sequenced,   732/732
(100 %)
1 diff
(99.9 %id)
BX401224   .b 713 to 1464 749 to 1   fully sequenced,   749/749
(100 %)
5 diff
(99.4 %id)
BX384640   .b 713 to 1465 753 to 1   fully sequenced,   753/753
(100 %)
2 diff
(99.8 %id)
CU456672 epidermis .b 713 to 1498 790 to 5     Submitted on the opposite strand 786/790
(99 %)
8 diff
(99.0 %id)
TI_1948094086   .b 713 to 1368 783 to 128   fully sequenced,   656/783
(83 %)
0 diff
(100 %id)
CU443535 epidermis .b 726 to 1498 777 to 5     Submitted on the opposite strand 773/777
(99 %)
11 diff
(98.6 %id)
CU447788 epidermis .b 726 to 1489 776 to 13     Submitted on the opposite strand 764/776
(98 %)
2 diff
(99.8 %id)
BE886628 leiomyosarcoma, uterus .b 741 to 1500 1 to 756   AAA   756/756
(100 %)
18 diff
(97.7 %id)
BX435991 T cells (Jurkat cell line) .b 744 to 1500 757 to 1       757/846
(89 %)
16 diff
(98.2 %id)
TI_149311563   .b 746 to 1497 881 to 138   AAA   744/893
(83 %)
22 diff
(97.6 %id)
TI_154132203   .b 750 to 1501 850 to 102   AAA   749/749
(100 %)
30 diff
(96.0 %id)
TI_1948093918   .b 761 to 1368 734 to 127   fully sequenced,   608/734
(82 %)
0 diff
(100 %id)
CA450602 Human Lung Epithelial cells, lung .b 787 to 1497 729 to 19   AAA   711/711
(100 %)
2 diff
(99.8 %id)
TI_149285676   .b 788 to 1497 795 to 86   AAA   710/710
(100 %)
3 diff
(99.6 %id)
TI_45235514   .b 792 to 1453 672 to 1   fully sequenced,   672/672
(100 %)
20 diff
(97.1 %id)
CD370288 Alveolar Macrophage, lung .b 793 to 1497 723 to 19   AAA   705/705
(100 %)
1 diff
(99.9 %id)
CF129849 Chondrosarcoma Lung Metastasis cell lines, lung .b 795 to 1499 1 to 702   AAA   702/702
(100 %)
5 diff
(99.3 %id)
TI_154191734   .b 795 to 1499 52 to 753   AAA   702/702
(100 %)
5 diff
(99.3 %id)
CD365922 Alveolar Macrophage, lung .b 807 to 1497 710 to 19   AAA   692/692
(100 %)
2 diff
(99.8 %id)
TI_149304203   .b 813 to 1497 790 to 105   AAA   686/687
(99 %)
2 diff
(99.8 %id)
BQ010168 Chondrosarcoma, Left Pubic Bone .b 814 to 1497 702 to 19   AAA   684/684
(100 %)
1 diff
(99.9 %id)
TI_149297659   .b 822 to 1501 762 to 83   AAA   680/938
(72 %)
2 diff
(99.8 %id)
BM982684 lung, Primary Lung Cystic Fibrosis EpithelialCells .b 823 to 1501 697 to 19   AAA   679/679
(100 %)
2 diff
(99.8 %id)
BX330766   .b 825 to 1488 664 to 1       664/743
(89 %)
17 diff
(97.8 %id)
BM700054 eye, lens .b 826 to 1118 1 to 293   fully sequenced,   293/293
(100 %)
0 diff
(100 %id)
CF129086 Chondrosarcoma Lung Metastasis cell lines, lung .b 835 to 1497 1 to 663   AAA   663/663
(100 %)
2 diff
(99.7 %id)
CB156079 Liver .b 835 to 1412 1 to 578       578/578
(100 %)
2 diff
(99.7 %id)
TI_154190641   .b 835 to 1497 52 to 714   AAA   663/663
(100 %)
2 diff
(99.7 %id)
BP316328 pericardium .b 865 to 1446 1 to 582       582/582
(100 %)
3 diff
(99.5 %id)
BQ000932 lung, Metastatic Chondrosarcoma .b 867 to 1497 649 to 19   AAA   631/631
(100 %)
1 diff
(99.9 %id)
BU676925 lung, Primary Lung Epithelial Cells .b 867 to 1497 649 to 19   AAA   631/631
(100 %)
2 diff
(99.7 %id)
BM981988 lung, Primary Lung Cystic Fibrosis EpithelialCells .b 867 to 1497 649 to 19   AAA   631/631
(100 %)
1 diff
(99.9 %id)
CB851759 lung, Primary Lung Cystic Fibrosis EpithelialCells .b 867 to 1495 647 to 19   AAA   629/629
(100 %)
2 diff
(99.7 %id)
CB853498 Human Lung Epithelial cells, lung .b 867 to 1497 647 to 19   AAA   629/629
(100 %)
2 diff
(99.7 %id)
CB250494 Human Lung Epithelial cells, lung .b 867 to 1497 649 to 19   AAA   631/631
(100 %)
3 diff
(99.6 %id)
BM679173 eye, fetal eye .b 867 to 1497 649 to 19   AAA   631/631
(100 %)
2 diff
(99.7 %id)
CA442814 Fibrosarcoma .b 867 to 1497 649 to 19   AAA   631/631
(100 %)
1 diff
(99.9 %id)
BQ772911 Chondrosarcoma Cell line .b 867 to 1497 649 to 19   AAA   631/631
(100 %)
1 diff
(99.9 %id)
CA428768 Cell Line, Chondrosarcoma .b 867 to 1501 653 to 19   AAA   635/635
(100 %)
2 diff
(99.7 %id)
BM971571 lung .b 869 to 1497 647 to 19   AAA   629/629
(100 %)
1 diff
(99.9 %id)
CA448466 Chondrosarcoma, Left Pelvis .b 869 to 1501 651 to 19   AAA   633/633
(100 %)
1 diff
(99.9 %id)
BQ776145 Bone, Human Chondrosarcoma Cell Line .b 869 to 1501 651 to 19   AAA   633/633
(100 %)
1 diff
(99.9 %id)
CA308622 Alveolar Macrophage, lung .b 869 to 1497 647 to 19   AAA   629/629
(100 %)
2 diff
(99.7 %id)
BQ003452 Chondrosarcoma, Left Pelvis .b 876 to 1497 640 to 19   AAA   622/622
(100 %)
3 diff
(99.6 %id)
BU681079 lung .b 880 to 1497 636 to 19   AAA   618/618
(100 %)
3 diff
(99.6 %id)
BX329573 Neuroblastoma Cot 25-normalized .b 884 to 1491 608 to 1   fully sequenced,   608/608
(100 %)
8 diff
(98.7 %id)
BI871686 adenocarcinoma, cell line, Liver .b 884 to 1497 1 to 614   AAA   614/614
(100 %)
1 diff
(99.9 %id)
CD103498 Pooled-Skin .b 884 to 1494 1 to 611       611/613
(99 %)
4 diff
(99.4 %id)
TI_57230827   .b 884 to 1497 55 to 668   AAA   614/614
(100 %)
1 diff
(99.9 %id)
BM754203 Ascites, stomach .b 887 to 1401 1 to 515       515/515
(100 %)
1 diff
(99.9 %id)
BU543644 carcinoma, cell line, Prostate .b 895 to 1497 1 to 603   AAA   603/603
(100 %)
1 diff
(99.9 %id)
BM670551 eye, lens .b 899 to 1497 617 to 19   fully sequenced, AAA   599/599
(100 %)
2 diff
(99.7 %id)
BE875701 large cell carcinoma, undifferentiated, lung .b 904 to 1451 1 to 550       550/551
(99 %)
4 diff
(99.3 %id)
CN480991 eye .b 919 to 1497 609 to 31   AAA   579/579
(100 %)
9 diff
(98.5 %id)
BG215656   .b 927 to 1483 571 to 13     Submitted on the opposite strand 559/571
(97 %)
5 diff
(99.2 %id)
DB366603   .b 932 to 1497 567 to 1       567/567
(100 %)
10 diff
(98.3 %id)
CU457083 epidermis .b 938 to 1491 566 to 13     Submitted on the opposite strand 554/566
(97 %)
3 diff
(99.5 %id)
CA416118 Chondrosarcoma Cell line .b 953 to 1501 567 to 19   AAA   549/549
(100 %)
1 diff
(99.9 %id)
DB354578 whole embryo, mainly head .b 954 to 1497 547 to 1       547/547
(100 %)
10 diff
(98.2 %id)
AW574830 lymph .b 956 to 1501 563 to 18   AAA   546/546
(100 %)
1 diff
(99.9 %id)
BM970413 lung .b 956 to 1497 560 to 19   AAA   542/542
(100 %)
2 diff
(99.7 %id)
DB294919   .b 980 to 1501 522 to 1       522/522
(100 %)
2 diff
(99.7 %id)
BP265103 muscle .b 981 to 1447 1 to 467       467/467
(100 %)
2 diff
(99.6 %id)
AI553894 anaplastic oligodendroglioma, brain .b 987 to 1501 515 to 1       515/515
(100 %)
3 diff
(99.5 %id)
AI131023 heart .b 990 to 1498 509 to 1       509/509
(100 %)
2 diff
(99.7 %id)
F22743 pectoral muscle (after mastectomy) .b 996 to 1470 1 to 473       473/473
(100 %)
4 diff
(99.2 %id)
AW068806 Bone, Hip .b 998 to 1503 526 to 17       510/530
(96 %)
8 diff
(98.5 %id)
AA488652   .b 999 to 1497 510 to 14   fully sequenced, AAA   497/497
(100 %)
8 diff
(98.4 %id)
DB521885 testis .b 1011 to 1497 1 to 487     Submitted on the opposite strand 487/487
(100 %)
2 diff
(99.6 %id)
AI918134 anaplastic oligodendroglioma, brain .b 1013 to 1503 494 to 6       489/494
(98 %)
2 diff
(99.6 %id)
AW246594 lung, small cell carcinoma .b 1018 to 1501 494 to 11   AAA   484/484
(100 %)
3 diff
(99.4 %id)
BQ360593 ovary .b 1019 to 1304 1 to 288       288/289
(99 %)
17 diff
(94.2 %id)
DB552749 hippocampus .b 1020 to 1497 1 to 478     Submitted on the opposite strand 478/478
(100 %)
2 diff
(99.6 %id)
AI131281 heart .b 1024 to 1503 480 to 1       480/480
(100 %)
2 diff
(99.6 %id)
BI860754 breast, mammary adenocarcinoma, cell line .b 1024 to 1497 1 to 474   AAA   474/474
(100 %)
1 diff
(99.8 %id)
TI_57192332   .b 1024 to 1497 50 to 523   AAA   474/474
(100 %)
1 diff
(99.8 %id)
DB576555 hypothalamus .b 1038 to 1499 1 to 462     Submitted on the opposite strand 462/464
(99 %)
3 diff
(99.4 %id)
AW674016 cervix .b 1054 to 1498 446 to 2       445/446
(99 %)
1 diff
(99.8 %id)
BU737856 eye, lens .b 1057 to 1501 464 to 20   fully sequenced, AAA   445/445
(100 %)
2 diff
(99.6 %id)
DB554353 hypothalamus .b 1058 to 1497 1 to 440     Submitted on the opposite strand 440/440
(100 %)
3 diff
(99.4 %id)
AA074315 Pancreas .b 1062 to 1464 408 to 4       405/408
(99 %)
3 diff
(99.3 %id)
BE544890 cervical carcinoma cell line, cervix .b 1083 to 1341 1 to 260       260/413
(62 %)
10 diff
(97.6 %id)
TI_57148288   .b 1095 to 1497 25 to 424   AAA   400/424
(94 %)
8 diff
(98.2 %id)
BE089294 breast .b 1102 to 1468 368 to 1     Submitted on the opposite strand 368/368
(100 %)
4 diff
(99.0 %id)
AW673852 cervix .b 1109 to 1497 400 to 12   AAA   389/389
(100 %)
3 diff
(99.3 %id)
BF820880 kidney_tumor .b 1138 to 1446 309 to 1     Submitted on the opposite strand 309/309
(100 %)
1 diff
(99.7 %id)
BF820882 kidney_tumor .b 1138 to 1446 309 to 1     Submitted on the opposite strand 309/309
(100 %)
1 diff
(99.7 %id)
T51626 fetal spleen, Spleen .b 1156 to 1451 300 to 1       300/321
(93 %)
8 diff
(97.6 %id)
BG219789   .b 1234 to 1494 267 to 7     Submitted on the opposite strand 261/267
(97 %)
6 diff
(97.8 %id)
AI624784 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .b 1235 to 1498 264 to 1       264/264
(100 %)
0 diff
(100 %id)
BF154407 breast_normal .b 1261 to 1492 230 to 1       230/274
(83 %)
7 diff
(97.5 %id)
AW834499 testis .b 1284 to 1400 1 to 117       117/122
(95 %)
9 diff
(92.7 %id)
AI244869 Kidney .b 1291 to 1503 217 to 5       213/224
(95 %)
0 diff
(100 %id)
F25531 pectoral muscle (after mastectomy) .b 1291 to 1494 14 to 215       202/215
(93 %)
6 diff
(97.3 %id)
F18389 pectoral muscle (after mastectomy) .b 1292 to 1498 1 to 208       208/208
(100 %)
11 diff
(94.8 %id)
FN165458 breast carcinoma .b 1301 to 1365 1 to 65       65/65
(100 %)
2 diff
(97.0 %id)
F34437 pectoral muscle (after mastectomy) .b 1317 to 1483 1 to 167       167/167
(100 %)
7 diff
(95.9 %id)
AI206339 pooled germ cell tumors .b 1328 to 1498 173 to 3       171/173
(98 %)
0 diff
(100 %id)
AI867459 pooled germ cell tumors .b 1328 to 1498 173 to 3       171/173
(98 %)
0 diff
(100 %id)
BE503721 pooled germ cell tumors .b 1328 to 1498 173 to 3       171/173
(98 %)
0 diff
(100 %id)
EC536834 Prostate .b 1358 to 1463 7 to 109       103/109
(94 %)
6 diff
(94.5 %id)
BI255302 cervical carcinoma cell line, cervix .b 1359 to 1501 1 to 143   AAA   143/143
(100 %)
0 diff
(100 %id)
AA452687   .b 1375 to 1487 1 to 112       112/112
(100 %)
1 diff
(99.2 %id)
EC516141 Prostate .b 1394 to 1496 102 to 1       102/103
(99 %)
1 diff
(99.1 %id)
BU171687 melanotic melanoma, skin .b 1410 to 1497 12 to 99   AAA   88/99
(88 %)
6 diff
(94.0 %id)
AI189050 placenta .b 1416 to 1497 102 to 21   AAA   82/82
(100 %)
1 diff
(98.8 %id)
BG205010   .c 1 to 764 1 to 764   tiling clone,   764/764
(100 %)
4 diff
(99.5 %id)
AW881221 ovary .c 263 to 622 1 to 359   tiling clone,   359/359
(100 %)
2 diff
(99.5 %id)
T29983 thymus gland .c 313 to 589 1 to 277       277/277
(100 %)
1 diff
(99.7 %id)
BF083118 colon_est .c 316 to 440 128 to 3       126/128
(98 %)
0 diff
(100 %id)
FN118336 breast carcinoma .c 320 to 390 1 to 72       72/72
(100 %)
4 diff
(94.5 %id)
BF748603 breast_normal .c 342 to 724 386 to 2     Submitted on the opposite strand 385/386
(99 %)
0 diff
(100 %id)
T31147 brain .c 357 to 681 1 to 326       326/326
(100 %)
2 diff
(99.4 %id)
BM845341 myeloma .c 490 to 594 1 to 105       105/105
(100 %)
0 diff
(100 %id)
BE837803 prostate_normal .c 582 to 747 381 to 216   tiling clone,   166/200
(83 %)
0 diff
(100 %id)
BX455696 brain, fetal brain .c 643 to 1410 773 to 9   tiling clone,   765/864
(88 %)
16 diff
(98.2 %id)
AI281322 adenocarcinoma, colon .c 999 to 1428 430 to 1   tiling clone,   430/430
(100 %)
2 diff
(99.6 %id)
BF848130 lung_normal .c 1130 to 1309 1 to 180   tiling clone,   180/183
(98 %)
10 diff
(94.6 %id)
DB505286 hypothalamus .d 1 to 452 5 to 456   tiling clone,   456/456
(100 %)
2 diff
(99.6 %id)
CU445753 epidermis .d 290 to 1040 1 to 752   tiling clone,   752/752
(100 %)
5 diff
(99.4 %id)
CR620232 neuroblastoma .e 1 to 1085 5 to 1089 exact tiling clone,   1089/1089
(100 %)
0 diff
(100 %id)
AL519149 brain, neuroblastoma, neuroblastoma cells .e 1 to 866 5 to 870       870/870
(100 %)
1 diff
(99.9 %id)
BX464478 neuroblastoma .e 1 to 885 5 to 889       889/898
(98 %)
7 diff
(99.3 %id)
BG258809 embryonal carcinoma, cell line, testis .e 30 to 816 1 to 785       785/785
(100 %)
12 diff
(98.5 %id)
AY421759   .f 1 to 1122 1 to 1121 C235S tiling clone,   1121/1128
(99 %)
5 diff
(99.6 %id)
AA352135   .g 1 to 335 1 to 336   tiling clone,   336/336
(100 %)
2 diff
(99.5 %id)
BE748506 bone marrow, from acute myelogenous leukemia .g 244 to 1065 833 to 9   tiling clone,   825/861
(95 %)
26 diff
(97.0 %id)
AA805268 germinal center B cell .g 701 to 1127 442 to 17   tiling clone, AAA   426/426
(100 %)
5 diff
(98.9 %id)
BE748207 bone marrow, from acute myelogenous leukemia .h 1 to 713 1 to 708 K150E N151K D152* tiling clone,   708/723
(97 %)
22 diff
(97.0 %id)
BQ335029 marrow .h 136 to 549 1 to 417   tiling clone,   416/417
(99 %)
25 diff
(94.1 %id)
EL948520 eyeball .i-u 1 to 493 1 to 494   tiling clone,   494/494
(100 %)
3 diff
(99.4 %id)
AW003567 pooled germ cell tumors .i-u 13 to 417 1 to 405   tiling clone, Submitted on the opposite strand 405/405
(100 %)
0 diff
(100 %id)
AI990231 pooled germ cell tumors .i-u 47 to 417 1 to 371     Submitted on the opposite strand 371/371
(100 %)
0 diff
(100 %id)
AI963955 pooled germ cell tumors .i-u 47 to 421 1 to 375     Submitted on the opposite strand 375/376
(99 %)
3 diff
(99.3 %id)
AI798893 pooled .i-u 486 to 957 472 to 1 P70A F81L C97Y tiling clone,   472/472
(100 %)
14 diff
(97.1 %id)
AA761860 germinal center B cell .i-u 551 to 957 425 to 19   tiling clone, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 407/425
(95 %)
0 diff
(100 %id)
DA749254   .j 1 to 567 2 to 568 exact tiling clone, capped   567/567
(100 %)
0 diff
(100 %id)
AL537761 brain, fetal brain .j 219 to 1136 1 to 923   tiling clone,   923/923
(100 %)
5 diff
(99.5 %id)
BI031774 marrow .j 227 to 546 321 to 1       321/322
(99 %)
1 diff
(99.7 %id)
CV418125 nervous_tumor .j 268 to 557 36 to 324       289/324
(89 %)
6 diff
(98.2 %id)
CV418128 nervous_tumor .j 269 to 557 38 to 326       289/326
(88 %)
6 diff
(98.2 %id)
BF306807 muscle, rhabdomyosarcoma .j 305 to 1055 1 to 739   tiling clone,   739/804
(91 %)
31 diff
(96.2 %id)
BE294598 muscle, rhabdomyosarcoma .j 325 to 1025 1 to 702   tiling clone,   702/742
(94 %)
12 diff
(98.4 %id)
BE005055 breast_normal .j 405 to 661 260 to 4     Submitted on the opposite strand 257/270
(95 %)
0 diff
(100 %id)
BG945183 amnion_normal .j 1103 to 1367 267 to 1   tiling clone,   267/267
(100 %)
4 diff
(98.6 %id)
AL566979 brain, fetal brain .j 1213 to 2195 982 to 1   tiling clone,   982/982
(100 %)
22 diff
(97.8 %id)
DA100455 cerebellum .j 1333 to 1877 2 to 546   tiling clone, capped   545/545
(100 %)
0 diff
(100 %id)
N23901 nose, olfactory epithelium .j 1791 to 2247 456 to 1       456/458
(99 %)
10 diff
(97.9 %id)
BP396056 pancreatic islet .j 1804 to 2245 1 to 442   tiling clone, Submitted on the opposite strand 442/442
(100 %)
0 diff
(100 %id)
AA640970   .j 2007 to 2243 234 to 1       234/249
(93 %)
4 diff
(98.4 %id)
DA087266 cerebellum .k 1 to 572 2 to 576   capped   575/575
(100 %)
3 diff
(99.5 %id)
DA089564 cerebellum .k 1 to 566 2 to 568   tiling clone, capped   567/567
(100 %)
1 diff
(99.9 %id)
DA800534 brain .k 19 to 481 2 to 467   capped   466/466
(100 %)
3 diff
(99.4 %id)
AA150328 Pancreas .k 30 to 414 1 to 378       378/378
(100 %)
13 diff
(96.6 %id)
CR603823 adult brain .k 32 to 2087 1 to 2056   tiling clone,   2056/2056
(100 %)
0 diff
(100 %id)
BX444310 adult brain, brain .k 32 to 1067 1 to 1029       1029/1034
(99 %)
9 diff
(99.2 %id)
BX452490 adult brain, brain .k 858 to 1795 1 to 935       935/935
(100 %)
12 diff
(98.8 %id)
AA149929 Pancreas .k 1697 to 2122 429 to 5   tiling clone,   425/429
(99 %)
1 diff
(99.8 %id)
BQ961264 carcinoma, cell line, Prostate .l 1 to 803 1 to 807 H57P V64G N89I R94P L95P ... tiling clone,   807/963
(83 %)
19 diff
(98.1 %id)
BI862022 breast, mammary adenocarcinoma, cell line .m 1 to 682 1 to 684 exact tiling clone,   684/684
(100 %)
3 diff
(99.6 %id)
TI_57193616   .m 1 to 682 24 to 707 exact     684/684
(100 %)
3 diff
(99.6 %id)
BU752560 placenta .n-u 1 to 549 564 to 18 exact tiling clone, AAA   547/547
(100 %)
2 diff
(99.7 %id)
BU752534 placenta .n-u 86 to 549 482 to 18 exact tiling clone, AAA   465/465
(100 %)
2 diff
(99.6 %id)
AV752987 Pituitary .o-u 1 to 538 4 to 532 K2S I3E R4S K5Y L6S ... tiling clone,   532/534
(99 %)
9 diff
(98.4 %id)
DA386697 thalamus Gene MRPL37, variant not shown       capped      
CU455607 epidermis Gene MRPL37, variant not shown         Submitted on the opposite strand    
AA059064 eye, retina Gene MRPL37, variant not shown              
AA059296 eye, retina Gene MRPL37, variant not shown              
TI_149288575   Gene MRPL37, variant not shown       AAA This clone was ignored    
DB235062 trachea Gene MRPL37, variant not shown       capped      
DB350246 trachea Gene MRPL37, variant not shown              
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i-u, .j, .k, .l, .m, .n-u, .o-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI